Amrize (NYSE:AMRZ) Coverage Initiated by Analysts at Barclays

Barclays began coverage on shares of Amrize (NYSE:AMRZ) in a research report report published on Tuesday,Benzinga reports. The brokerage issued an equal weight rating on the stock.

Other research analysts have also recently issued research reports about the stock. Oppenheimer initiated coverage on shares of Amrize in a research note on Tuesday, September 9th. They issued an “outperform” rating and a $62.00 target price for the company. Royal Bank Of Canada decreased their price target on shares of Amrize from $61.00 to $54.00 and set an “outperform” rating for the company in a report on Friday, August 8th. Zacks Research cut shares of Amrize from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 27th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Amrize in a research report on Saturday, September 27th. Finally, JPMorgan Chase & Co. upped their target price on shares of Amrize from $52.00 to $60.00 and gave the company an “overweight” rating in a report on Tuesday, August 26th. Four investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $58.25.

Amrize Price Performance

AMRZ stock opened at $47.06 on Tuesday. Amrize has a twelve month low of $44.12 and a twelve month high of $56.29. The business’s 50-day moving average price is $50.90. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.85 and a current ratio of 1.38.

Amrize (NYSE:AMRZ) last released its earnings results on Wednesday, August 6th. The company reported $0.78 earnings per share for the quarter, missing analysts’ consensus estimates of $1.03 by ($0.25).

Insider Activity at Amrize

In other news, insider Jaime Hill purchased 4,000 shares of the business’s stock in a transaction dated Friday, August 15th. The stock was bought at an average price of $51.99 per share, with a total value of $207,960.00. Following the acquisition, the insider owned 13,601 shares in the company, valued at approximately $707,115.99. The trade was a 41.66% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CTO Roald Brouwer purchased 2,000 shares of the business’s stock in a transaction dated Wednesday, August 27th. The shares were purchased at an average cost of $51.88 per share, with a total value of $103,760.00. Following the acquisition, the chief technology officer owned 5,000 shares in the company, valued at $259,400. This trade represents a 66.67% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 1,124,000 shares of company stock worth $53,225,260 in the last 90 days.

Institutional Trading of Amrize

Institutional investors and hedge funds have recently made changes to their positions in the company. BNP Paribas Financial Markets bought a new stake in shares of Amrize during the 2nd quarter worth approximately $59,000. Groupe la Francaise bought a new stake in shares of Amrize during the 2nd quarter worth approximately $60,000. Allianz SE bought a new stake in shares of Amrize during the 2nd quarter worth approximately $80,000. Osaic Holdings Inc. bought a new position in Amrize in the 2nd quarter valued at approximately $90,000. Finally, Credit Industriel ET Commercial bought a new position in Amrize in the 2nd quarter valued at approximately $109,000.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.